Skip to main content
Signal8

Buell Jennifer

SEC insider (Form 3/4/5 filer). CIK 0001711184. Chief Executive Officer at MiNK Therapeutics, Inc. (INKT) and 1 other issuer. 20 reported Form 4/5 transactions since Sep 2024; latest on Oct 12, 2026. Located in NEW YORK, NY.

Companies Buell Jennifer has filed insider reports for

  • MiNK Therapeutics, Inc. (INKT): Director, Officer, Chief Executive Officer
  • AGENUS INC (AGEN): Director, Officer, See Remarks
Buell Jennifer profile photo

Buell Jennifer

CIK: 0001711184

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (5.0%)

Position reduction

Option Exercises (M)1 (5.0%)

Derivative conversions

Awards (A)15 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (15.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

MiNK Therapeutics, Inc. logo
INKT

MiNK Therapeutics, Inc.

DirectorOfficer
AGENUS INC logo
AGEN

AGENUS INC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (20 total)

  • MiNK Therapeutics, Inc. logo
    INKT

    MiNK Therapeutics, Inc.

    Oct 12, 2026
    Sale
    Direct
    6.9K shares at avg. $10.56$73K
  • MiNK Therapeutics, Inc. logo
    INKT

    MiNK Therapeutics, Inc.

    Oct 11, 2026
    Exercise
    Direct
    23.2K shares-
  • AGENUS INC logo
    AGEN

    AGENUS INC

    Aug 5, 2026
    Award

    Stock Option

    Direct
    200K shares-
  • AGENUS INC logo
    AGEN

    AGENUS INC

    Apr 24, 2026
    Award

    Stock Option

    Direct
    5K shares-
  • AGENUS INC logo
    AGEN

    AGENUS INC

    Apr 24, 2026
    Award

    Stock Option

    Direct
    300K shares-
  • MiNK Therapeutics, Inc. logo
    INKT

    MiNK Therapeutics, Inc.

    Jan 2, 2026
    Tax Payment
    Direct
    10K shares at avg. $11.12$111K
  • MiNK Therapeutics, Inc. logo
    INKT

    MiNK Therapeutics, Inc.

    Jan 2, 2026
    Award
    Direct
    31.5K shares at avg. $11.12$350K
  • MiNK Therapeutics, Inc. logo
    INKT

    MiNK Therapeutics, Inc.

    Sep 9, 2025
    Tax Payment
    Direct
    5.4K shares at avg. $15.36$82K
  • MiNK Therapeutics, Inc. logo
    INKT

    MiNK Therapeutics, Inc.

    Sep 9, 2025
    Award
    Direct
    18.2K shares at avg. $15.36$280K
  • AGENUS INC logo
    AGEN

    AGENUS INC

    May 2, 2025
    Award
    Direct
    581 shares at avg. $3.11$2K

1-10 of 20